test

Jeffrey Sundram

@Cowen And Company, Llc

Latest period2024 - Q3ReportedManaged Assets$2.969TTotal holdings564
Assets growth rate-18.35%Assets growth rate (2-Q avg)11.26%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Cowen And Company, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 564 positions.

Assets under management

The assets under management (AUM) of Cowen And Company, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.969T in assets, with a quarterly growth rate of -18.35% and a 2-quarter average growth rate of 11.26%. The portfolio is managed by Jeffrey Sundram, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
COINCoinbase Global Inc
Recent Activity
Decreased -14.34%
7.66%
$227.226B
1.275M shares@ $178170.0 avg price
METAMeta Platforms Inc
Recent Activity
Decreased -59.95%
5.98%
$177.353B
309,820 shares@ $572440.0 avg price
PTCTPtc Therapeutics Inc
Recent Activity
Decreased -4.41%
4.49%
$133.213B
3.591M shares@ $37100.0 avg price
AAPLApple Inc
Recent Activity
Decreased -38.71%
4.15%
$122.948B
823,959 shares@ $149216.39 avg price
AMDAdvanced Micro Devices Inc
Recent Activity
Decreased -67.21%
1.76%
$52.031B
317,107 shares@ $164080.0 avg price
STOKStoke Therapeutics Inc
Recent Activity
Decreased -3.6%
1.35%
$39.875B
3.244M shares@ $12290.0 avg price
ESTAEstablishment Labs Hldgs Inc
Recent Activity
Decreased -7.44%
1.27%
$37.643B
869,948 shares@ $43270.0 avg price
URGNUrogen Pharma Ltd
Recent Activity
Decreased -14.42%
0.77%
$22.817B
1.797M shares@ $12700.0 avg price
AACTAres Acquisition Corp Ii
Recent Activity
Decreased -40.66%
0.72%
$21.26B
1.963M shares@ $10830.0 avg price
SMFGSumitomo Mitsui Finl Group I
Recent Activity
Decreased -44.29%
0.67%
$19.706B
1.56M shares@ $12630.0 avg price